@lungcancereurope.bsky.social‼️ Our 12th Annual Report Survey closes this Wednesday, 14 October.
Thank you to everyone who has already shared their experience.
If you’re living with #lungcancer or caring for someone who is and haven’t taken part yet, there’s still time:
es.surveymonkey.com/r/LungCancer...
@lungcancereurope.bsky.socialBelgium has announced a 🆕 10-yr cancer plan, inclu plans to concentrate complex #lungcancer care in specialist centres from 2028.
The plan also includes a national expert panel to support difficult trtmt decisions.
The challenge now is turning these commitments into better, accessible care. #LCSM
@lcrf.orgThank you to Biodesix for your support as a sponsor of the Free to Breathe Anywhere Walk! #FreeToBreatheWalk #LungCancer #ThankYou
@alkpositiveuk.bsky.socialA huge thank you to Stephen, who swam 2 miles at Swim Serpentine to raise funds for ALK Positive #LungCancer UK! 💙
Stephen joined 4,600 swimmers in London’s Hyde Park, completing his swim in 1 hour 34 minutes.
Well done, Stephen, and thank you for supporting our ALK+ lung cancer community! 👏 #LCSM
@lcrf.orgHave you signed up for the Free to Breathe Anywhere Walk to support #LungCancer research? The official walk weekend is Oct 17-18, but you can participate any time (and place) that works for you! Find out more at lcrf.org/anywhere.
@lcrf.orgThank you to Johnson & Johnson for being a generous sponsor and partner of the Free to Breathe National Walk Program!
@breakingnews06.bsky.socialLetter from the Editor-in-Chief: Lung Cancer Can Look Like Anyone #LungCancer #NonSmokers #CancerAwareness #EGFRPositive #HealthTalk
@lcrf.orgThank you to Nuvation Bio for your support as a sponsor of the Free to Breathe Chicago Walk! #FreeToBreatheWalk #LungCancer #ThankYou
@alkpositive.bsky.socialALK Positive helped fund researchers at @BIDMChealth @DanaFarber & more to help immune cells attack cancer. Early results are in lymphoma; the approach is now being explored in #lungcancer.
@lungcancereurope.bsky.socialGood news for #lungcancer screening in Europe.
Poland is launching a nationally funded lung cancer screening programme this Oct, offering free low-dose CT scans to people at higher risk.
Access to early detection still varies widely across Europe. This is an important step forward. #LCSM
@allyouneedislungs.bsky.socialHow can we spot #lungcancer earlier in people who have never smoked?
A new review found 31 existing prediction models, but none met all quality standards.
More research is needed to help identify who may be at risk.
@oncogenecancer.bsky.socialWhat does progress in #lungcancer mean for everyday life? Why do patient voices matter in research?
Our Chair &
@alkpositive.bsky.social
BoD
@yvonnediaz.bsky.social
&
@dryolaolo.bsky.social
discuss all in a takeover of
@iaslc.bsky.social ’s Lung Cancer Considered podcast
🎧 bit.ly/3TA4gv3
@vcclibrary.bsky.socialLazertinib Plus Pemetrexed and Carboplatin in Patients With EGFR-Mutant Advanced Non-Small Cell #LungCancer after Progression on Lazertinib. www.ejcancer.com/article/S095...
@lungcancereurope.bsky.socialAround 1,700 #lungcancer cases could be prevented across the EU over the next 40 years under stronger workplace protections, according to the European Commission.
The European Parliament backed the new rules this week.
@allyouneedislungs.bsky.socialWhy do people who have never smoked develop #lungcancer?
The UK’s OLIVE study is looking at who is affected, how lung cancer is diagnosed and outcomes, with the aim of improving diagnosis and care. #LCSM
@jamainternalmed.comAmong patients due for annual #LungCancer screening, stepped reminders to primary care physicians to order and patients to schedule low-dose computed tomography increased guideline-concordant screening adherence vs usual care. ja.ma/4zcBboo
@vcclibrary.bsky.socialSmoking Cessation Among Underserved Patients Referred for #LungCancer Screening: A Randomized Clinical Trial. jamanetwork.com/journals/jam...
@tamedoncol.bsky.socialGet ready for #ESMO26 by revisiting the evolving treatment landscape of #SCLC with this review published on #TAMO in 2025.
From current standards to DLL3-targeted therapies, #ADCs and emerging biomarkers.
#Lungcancer
🔗 buff.ly/B2U9VpQ
@Roya_Behrouzi @fblackhall
@go2forlungcancer.bsky.socialThere are many ways to #ShineALight on #LungCancer.
Host an in-person or virtual event, or create an educational display to bring your community together during #LungCancerAwarenessMonth this November. 🫁
Learn more and register. 👉 hcp.go2.org/shine-a-light/
@lungcancereurope.bsky.social🆕 research looks at what may happen before some smoking-related lung cancers develop.
Long-term cigarette smoke exposure changed lung stem cells in a lab model, with KRAS linked to adenocarcinoma and TP53 loss to squamous cell carcinoma. #LCSM #lungcancer
